Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 19/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.91 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.91 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1387378 | 1.00 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL1387472 | 1.00 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6755361 | 0.98 | PDE4A (0.95) | PDE4APDE4DPDE4BPDE4C | |
| Cdp840 SCHEMBL84490 | 0.95 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| Cdp840 SCHEMBL29412448 | 0.95 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| Cdp840 SCHEMBL1389110 | 0.95 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| Cdp840 SCHEMBL153739 | 0.95 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6251077 | 0.95 | PDE4A (0.92) | PDE4APDE4DPDE4BPDE4C | |
| Cdp840 SCHEMBL29351573 | 0.95 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL6861670 | 0.94 | PDE4A (1.00) | PDE4APDE4DPDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3581713-B2 | — | — | 2004-10-27 | — | — | JP | claimed |
| EP-0626939-B1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CELLTECH THERAPEUTICS LTD (GB) | 2001-11-07 | — | — | EP | claimed |
| JP-H09510691-A | — | — | 1997-10-28 | — | — | JP | claimed |
| US-5622977-A | ANTIINFLAMMATORY AGENT, ANTIALLERGENS | CELLTECH THERAPEUTICS LIMITED (GB) | 1997-04-22 | — | — | US | claimed |
| EP-0736010-A1 | AN ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF CHIRAL TRIARYL DERIVATIVES AND CHIRAL INTERMEDIATES FOR USE THEREIN | CELLTECH THERAPEUTICS LIMITED (GB) | 1996-10-09 | — | — | EP | claimed |
| WO-1995017386-A1 | AN ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF CHIRAL TRIARYL DERIVATIVES AND CHIRAL INTERMEDIATES FOR USE THEREIN | CELLTECH THERAPEUTICS LIMITED (GB) | 1995-06-29 | — | — | WO | claimed |
| EP-0626939-A1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1994-12-07 | — | — | EP | claimed |
| WO-1994014742-A1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CELLTECH LIMITED (GB) | 1994-07-07 | — | — | WO | claimed |
| EP-0626939-B1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CELLTECH THERAPEUTICS LTD (GB) | 2001-11-07 | — | — | EP | disclosed |
| US-5622977-A | ANTIINFLAMMATORY AGENT, ANTIALLERGENS | CELLTECH THERAPEUTICS LIMITED (GB) | 1997-04-22 | — | — | US | disclosed |
| US-5608070-A | ENZYME INHIBITOR; ANTIINFLAMMATORY, BRONCHODILATOR AGENTS | CELLTECH THERAPEUTICS LIMITED (GB) | 1997-03-04 | — | — | US | disclosed |
| EP-0736010-A1 | AN ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF CHIRAL TRIARYL DERIVATIVES AND CHIRAL INTERMEDIATES FOR USE THEREIN | CELLTECH THERAPEUTICS LIMITED (GB) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995017386-A1 | AN ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF CHIRAL TRIARYL DERIVATIVES AND CHIRAL INTERMEDIATES FOR USE THEREIN | CELLTECH THERAPEUTICS LIMITED (GB) | 1995-06-29 | — | — | WO | disclosed |
| EP-0626939-A1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1994-12-07 | — | — | EP | disclosed |
| WO-1994014742-A1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | CELLTECH LIMITED (GB) | 1994-07-07 | — | — | WO | disclosed |